Early Alzheimer’s disease has been linked to relatively low levels of a range of nutrients in the bodies despite having a normal diet.
These nutrients are necessary for the creation of new connections in the brain called synapses. The loss of synapses is one of the key signs of early Alzheimer’s disease.
Omega 3 fatty acids, uridine monophosphate and choline, as well as several key vitamins, all work together to help create new synapses
Souvenaid is an innovative product for the management of early Alzheimer’s disease and contains a unique combination of nutrients at levels that are difficult to achieve from diet alone